Navigation Links
Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
Date:4/16/2009

First Quarter 2009 Financial Results

VANCOUVER, April 16 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the first quarter ended March 31, 2009, on Thursday April 30, 2009 at 11:00 AM ET (8:00 AM Pacific).

    Dial-in information for the earnings call on April 30, 2009 is as
    follows:
    North America (toll-free): (800) 901-5247
    International: (617) 786-4501
    Enter Passcode: 72734002

A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.

A press release announcing Angiotech's financial results will be issued prior to the call on April 30 at approximately 8:00 AM ET (5:00 AM Pacific).

An archived replay of the call will be available until May 7, 2009.

    Replay information is as follows:
    North America (toll-free): (888) 286-8010
    International: (617) 801-6888
    Enter Passcode: 95526962

    About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
2. Angiotech announces positive results from Bio-Seal(TM) clinical study
3. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
4. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
5. Angiotech Pharmaceuticals announces time change of conference call and webcast
6. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
7. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
8. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
9. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
10. Angiotech wins before the UK House of Lords
11. Angiotech to Establish Separate Operating and Royalty Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
(Date:12/22/2014)... HILL, N.C. , Dec. 22, 2014 /PRNewswire/ ... today announced that it has signed a letter ... company that has developed and patented a nanotechnology-based ... medical diagnostics products that enable rapid on-site collection ... alcohol use/abuse and health issues in an immediate, ...
(Date:12/22/2014)... , Dec. 22, 2014  ( www.competitivehealth.com ) ... an online medical bill review and advocacy service, has ... the FREE WellCard Savings discount health services marketplace. ... that was more than they expected to pay. As ... health care costs, WellCard Savings is pleased to offer ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... the United States have modified a strain of bacteria ... published in Biotechnology and Bioengineering, reveals how ... improvement, a positive development for the biofuel industry. ... bacterium noted for its bio-ethanol producing potential. However, the ...
... 2010 ACCESS PHARMACEUTICALS, INC. ... leveraging its proprietary drug-delivery platforms to develop treatments in areas ... definitive agreements with existing and new accredited investors to sell, ... million shares of its common stock at a price of ...
... NEW YORK, Dec. 10, 2010 Pfizer Inc. (NYSE: ... interest of patient safety, it is voluntarily withdrawing Thelin® ... in regions where it is approved (the European Union, ... studies of Thelin worldwide. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Biology Technology:Bioengineers develop bacterial strain to increase ethanol biofuel production 2Access Pharmaceuticals Raises $6.0 Million In Registered Direct Offering 2Access Pharmaceuticals Raises $6.0 Million In Registered Direct Offering 3Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety 2Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety 3
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... crops places huge demands on water resources around ... is a major contributor to the nation,s economy, ... the agricultural sector. The excessive use of irrigation ... Mediterranean countries, where rising demand has deteriorated groundwater ...
... agricultural land could produce enough biomass to meet renewable ... environment, according to research led by Professor Gail Taylor ... by the UK Energy Research Centre (UKERC), is a ... the potential of planting short rotation coppice (poplar and ...
... will not only teach us more about the way neurons ... diagnostics and therapies for neurological diseases such as Parkinson,s," says ... take a major toll on society. More than 8% of ... cent suffers from a mental disturbance and the number of ...
Cached Biology News:Research on satellite imagery aims to advance sustainable agriculture 2Short rotation energy crops could help meet UK's renewable energy targets 2Skywalker ensures optimal communication between neurons 2
... uses the Adept CE 4100 high pressure dual ... detector for added flexibility and utra low drift. ... to a photodiode array detection and provides superior ... required for method development and for monitoring to ...
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... number is a new ... easily match Cornings product ... availability yet, please order ... number (Z71,448-8) or contact ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
Biology Products: